Open-label extension study for patients with severe chronic lower back pain or severe chronic pain due to osteoarthritis of the knee who have completed any of the previous clinical trials of phase IIIb tapentadol hydrochloride KF5503/42 codes, KF5503/43, KF5503/44 or KF5503 / 45. [Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb de clorhidrato de tapentadol códigos KF5503/42, KF5503/43, KF5503/44 o KF5503/45.]

Trial Profile

Open-label extension study for patients with severe chronic lower back pain or severe chronic pain due to osteoarthritis of the knee who have completed any of the previous clinical trials of phase IIIb tapentadol hydrochloride KF5503/42 codes, KF5503/43, KF5503/44 or KF5503 / 45. [Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb de clorhidrato de tapentadol códigos KF5503/42, KF5503/43, KF5503/44 o KF5503/45.]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Grunenthal
  • Most Recent Events

    • 09 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top